A Study to Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

NCT01763307 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Rash Due to Epidermal Growth Factor Receptor Inhibitors

Interventions

DRUG: RECONVAL CREAM
DRUG: PLACEBO

Sponsor

Hadassah Medical Organization